[ad_1]
The United States Food and Drug Administration has reduced the age of those likely to receive the vaccine in the United States to 12, a step that is expected to deliver millions of additional vaccines.
And the “Pfizer-Biontech” vaccine was licensed for use in people 16 years of age and older last December, ahead of the latest amendment, which includes younger groups (12 to 15 years old).
On the US Food and Drug Administration (FDA) website, Acting Commissioner Janet Woodock described the mandate as “an important step in the fight against the pandemic (Covid 19)”.
Woodcock wrote that this measure “helps protect the younger population of Corona, which brings us closer to a sense of normalcy and the end of the pandemic.”
And last week, US President Joe Biden said the administration “is ready to act immediately to prepare approximately 20,000 drugstore sites across the country to vaccinate these teens, once the Food and Drug Administration gives its approval. “.
The department also plans to send the vaccines directly to pediatric clinics, where parents may feel more comfortable discussing their children’s immunizations.
At the end of March, the company told “Pfizer” that data from the third phase of clinical trials showed that its vaccine against “Covid 19” was 100% effective in preventing disease, in children aged 12 to 15 years.
The US pilot study included more than 2,200 people in this age group, about half of whom received real vaccines, while the rest received placebo injections.
According to the company, 18 people in the placebo group were diagnosed with “Covid 19”, and no cases were reported among those who received the vaccine.
The company says the vaccine is generally safe for children, with minimal side effects such as a mild fever or an infection in the arm.
And some children can get severe “Covid 19” infection, and they can die from it in rare cases, but most of them are not considered vulnerable to infection with the virus in adulthood.
[ad_2]
Source link
